Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ: TEM )

39.75 +2.25 (+6.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,630,588
Open 38.88
Bid (Size) 39.76 (1)
Ask (Size) 41.00 (7)
Prev. Close 37.50
Today's Range 37.68 - 41.78
52wk Range 22.89 - 43.88
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IPOs 2024: Tempus AI Addresses Medical Diagnostic Use Case
Tempus has been growing at a strong clip. Its revenues increased from $257.9 million in 2021 to $320.7 million in 2022 and to $531.8 million last year. 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures
The funds are intended to launch a series of new biotech companies that will harness the power of generative artificial intelligence for drug discovery. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
-1.24%
-1.24%
1 Month
-1.24%
-1.24%
3 Month
-1.24%
-1.24%
6 Month
-1.24%
-1.24%
1 Year
-1.24%
-1.24%

More News

Read More
Tempus Surpasses 500 Research Publications
From Tempus AI, Inc.
Via Business Wire
Tempus AI Has Massive Market Opportunity For This Healthcare Technology, Bullish Analyst Says
Via Benzinga
Topics Artificial Intelligence Initial Public Offering
Exposures Artificial Intelligence Securities Market
Tempus Could Gain Share In AI Health Care Market Poised To Grow By Over 30%
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSM
From Tempus AI, Inc.
Via Business Wire
IPO Watch: 3 New Stocks Worth a Strong Look
Via InvestorPlace
Topics Artificial Intelligence Initial Public Offering
Exposures Artificial Intelligence Securities Market
3 New IPOs That Could Be the Next Big Thing
Via InvestorPlace
Why Tempus AI (TEM) Stock Is Rising
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for its xT CDx Test
From Tempus AI, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Trump Media & Technology And Grindr Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 23 - June 29): Are These In Your Portfolio?
Via Benzinga
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Masayoshi Son's SoftBank To Raise $1.86B Through Bond Issuance For AI Investment And Debt Repayment
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
SoftBank Bets Big On AI In Healthcare: Inks New Joint Venture with Tempus To Transform Cancer Treatment In Japan
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib
From Tempus
Via Business Wire
This AI Stock Surges Nearly 3% Premarket As SoftBank Reportedly Plans To Launch AI-Powered Medical Service In Japan
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Google Invested in This Hot New Artificial Intelligence (AI) Stock. Should You?
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Onsemi Layoffs 2024: What to Know as Onsemi Cuts 1,000 Jobs
Via InvestorPlace
Topics Workforce
Exposures Layoff
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.